Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.04.2024 | Case report

Iodine-131/lenvatinib

Lack of efficacy

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Papini E, et al. Combined Treatment with Laser Ablation and Tyrosin Kinase Inhibitors. a Novel Multimodality Approach to Locally Advanced Thyroid Cancer?. Journal of the Endocrine Society 4 (Suppl.): A919 abstr. SUN-485, May 2020. Available from: URL: https://dx.doi.org/10.1210/jendso/bvaa046.1822 [abstract] Papini E, et al. Combined Treatment with Laser Ablation and Tyrosin Kinase Inhibitors. a Novel Multimodality Approach to Locally Advanced Thyroid Cancer?. Journal of the Endocrine Society 4 (Suppl.): A919 abstr. SUN-485, May 2020. Available from: URL: https://​dx.​doi.​org/​10.​1210/​jendso/​bvaa046.​1822 [abstract]
Metadaten
Titel
Iodine-131/lenvatinib
Lack of efficacy
Publikationsdatum
01.04.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-56885-x

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Multiple drugs

Case report

Deferasirox

Case report

Phenylephrine

Case report

Multiple drugs

Case report

Tozinameran